COVID-19 thromboembolism is reduced in ambulatory, but not hospitalized patients, following COVID-19 vaccination

• Hannah Stevens,
• Sergio Ruiz-Carmona,
• Karlheinz Peter,
• James McFadyen

Affiliations

Hannah Stevens

Department of Haematology, Alfred Hospital, Melbourne, Victoria, Australia 3004; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia; Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria

Sergio Ruiz-Carmona

Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne

Karlheinz Peter

Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia 3004; Department of Cardiology, Alfred Hospital, Melbourne, Australia 3004; Baker Department of Cardiometabolic Health, The University of Melbourne, Victoria

James McFadyen

Department of Haematology, Alfred Hospital, Melbourne, Victoria, Australia 3004; Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia; Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia 3004; Baker Department of Cardiometabolic Health, The University of Melbourne, Victoria